Presenter: G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD
In episode 485, Mike and James go over a couple of COVID trials that show two different anti-inflammatories – colchicine and inhaled budesonide – seem to have an effect on reducing hospitalizations or urgent care visits. 1) Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial Lancet…
In the Clinic Episode 42: Lower Urinary Tract Symptoms
In the Clinic Episode 41: Prenatal Screening for Fetal Anomalies
FM Rounds #18: Inclusive by Default: From Minority Stress to Trauma-Informed Primary Care

Presenter(s):
G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD
Please provide any additional comments (optional).